BMY.US: Opdivo not better than chemo in 44% of 2nd line lung cancer
Opdivo not better than chemo in 44% of 2nd line lung cancer: non-squamous, PD-L1-ve in CHECKMATE 057
As we suspected in our previous post, Opdivo has disapointed in 2nd line non-squamoous lung cancer